Read Time:7 Second
The Swiss pharmaceutical company reiterated its outlook, predicting single-digit growth this year, following an end to the slump in COVID-19-related sales.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
Average Rating